GlucoTrack, Inc. (NASDAQ:GCTK) Short Interest Down 97.3% in January

GlucoTrack, Inc. (NASDAQ:GCTK) was the target of a large decline in short interest in the month of January. As of January 31st, there was short interest totalling 32,900 shares, a decline of 97.3% from the January 15th total of 1,220,000 shares. Approximately 0.5% of the company’s shares are short sold. Based on an average daily volume of 3,070,000 shares, the days-to-cover ratio is presently 0.0 days.

Hedge Funds Weigh In On GlucoTrack

An institutional investor recently raised its position in GlucoTrack stock. Geode Capital Management LLC grew its position in shares of GlucoTrack, Inc. (NASDAQ:GCTK) by 315.3% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 112,787 shares of the company’s stock after acquiring an additional 85,626 shares during the period. Geode Capital Management LLC owned about 14.10% of GlucoTrack worth $42,000 at the end of the most recent quarter. 10.92% of the stock is owned by institutional investors.

GlucoTrack Trading Down 0.7 %

Shares of NASDAQ GCTK opened at $0.53 on Thursday. The firm has a fifty day simple moving average of $3.51 and a two-hundred day simple moving average of $24.47. GlucoTrack has a 12 month low of $0.49 and a 12 month high of $99.00. The firm has a market capitalization of $424,320.00, a PE ratio of -0.01 and a beta of -0.38.

About GlucoTrack

GlucoTrack, Inc, a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain.